Refreshing results…
T-cell Lymphoma and Secondary Primary Malignancy Risk After Commercial CAR T-cell Therapy
UploadAntigen glycosylation regulates efficacy of CAR T cells targeting CD19
Download from www.nature.comPembrolizumab for B-cell lymphomas relapsing after or refractory to CD19-directed CAR T-cell therapy
Download from ashpublications.orgAn NK-like CAR T cell transition in CAR T cell dysfunction
UploadStrategy to prevent epitope masking in CAR.CD19+ B-cell leukemia blasts
Download from doi.orgAntigen-independent activation enhances the efficacy of 4-1BB-costimulated CD22 CAR T cells
Download from www.nature.comIbrutinib enhances chimeric antigen receptor T-cell engraftment and efficacy in leukemia
Download from ashpublications.orgMissing publications? Search for publications with a matching author name.